Latest Advisories

  • FDA Advisory No. 2014-069 || Addendum to Public Healththe Use of Warning Against the Use of Unregistered Product "Prednisolone 5 mg per 5 mL Syrup (PRED)

  • FDA Advisory No. 2014-068 || Public Health Advisory on Taiwan Food and Drug Administration's Announced Lard Oil Products Believed to be Tainted with Recycled Waste Oil

    Read more...
  • FDA Advisory No. 2013-053-A || Update on FDA Advisory No. 2013-053 Re: Toxic Mercury-Laden Skin Whitening Cosmetic Products Without Notification that were Tested by the FDA

    Read more...
  • FDA Advisory No. 2014-067 || Food and Drug Administration (FDA) and Philippine Pharmacists Association (PPhA) Mull Plan to Authorize Community Pharmacists to Administer Vaccines

    Read more...
  • FDA Advisory No. 2014-066 || Voluntary Recall of Specific Batches of Tetrahydrozoline HCL 0.05% Opthalmic Solution (Eye-Mo Red Eyes Formula) with Registrationn Number DRHR-431

    Read more...

Announcement

  • Kapihan at Talakayan sa FDA

    To: All Concerned Paint Stakeholders
    From: Center for Cosmetics Regulation and Research (CCRR)
    Venue: Media Room - FDA Main Building
    Date: 25 September 2014 (Thursday)
    Time: 9:00 AM - 12:00 NN

    In the interest of the service, the Center for Cosmetics Regulation and Research (CCRR) shall conduct a "Kapihan at Talakayan sa FDA" on 25 September 2014, Thursday, 9:00 AM - 12:00 NN at Media Room - FDA Main Building, to open a forum of discussion to clarify some issues and concerns involving the Electronic Notification (eNotification) of selected Household/Urban Hazardous Substances (HUHS), particularly finished paint products.

    All concerned paint stakeholders are invited to attend. Registration by email at This email address is being protected from spambots. You need JavaScript enabled to view it. is on a first-come, first-serve basis and only twenty (20) participants (one representative per company) will be accommodated for this activity.

    For your information and guidance.

    Read more...
  • FDA Satellite Ofice - Ali Mall Cubao, Quezon City

    FDA Satellite Office - Ali Mall Cubao, Quezon City

    The Food and Drug Administration (FDA) Satellite Office in Ali Mall Cubao, Quezon City will start receiving applications for License to Operate (LTO), Certificate of Product Registration (CPR) and other authorizations following the Public Assistance, Information and Receiving (PAIR) procedure beginning 15 September 2014, Monday from 10am - 6pm. However, only those applications scheduled for the day with payment of appropriate fees and charges will be accepted. Applicant companies are further advised to submit product registrations for vaccines and biological at FDA Alabang.

    Submission of letter request and other communication such as ADRs/AEs, Clinical Trial Protocols and other related documents will be also received following the existence procedure.

    For your Information and Guidance.

  • To All Concerned

    This is to inform you that FDA Inventory System conducted system upgrade last September 12-13, 2014.

    Happy to inform you that the system is now fully operational.

    Thank You for bearing with us.

  • Public Consultation on the Draft Administrative Order on 2014-2015 Schedule of Fees and Rationalization of Services of the Center for Food Regulation and Research

    Public Consultation on the Draft Administrative Order on 2014-2015 Schedule of Fees and Rationalization of Services of the Center for Food Regulation and Research

    All food manufacturers, distributors, and other concerned parties are invited to attend the public consultation on the draft Administrative Order (AO) on 2014-2015 Schedule of Fees and Rationalization of Services of the Center for Food Regulation and Research. The particulars are as follows:

    Venue:    Audio-Visual Room, 3rd Floor Annex Bldg., FDA Compound, Civic Drive, Filinvest Corporate City, Alabang, Muntinlupa City
    Date: 12 September 2014 (Friday)
    Time: 1:30-3:30 pm

    The draft AO is posted at the FDA website for your reference. For confirmation, please email the CFRR through This email address is being protected from spambots. You need JavaScript enabled to view it. with the subject Public Consultation on Revised Fees.

    Thank you.

  • To All Concerned:

    This is to inform you that FDA conducted system upgrade last July 28 - 30 2014.

    Happy to inform you that the system is now fully operational.

    Thank You for bearing with us.

     

Videos

  • FDA Public Assistance Information and Receiving (PAIR) Video Tutorial

    A step by step guide to filing an application for a License to Operate or a Certificate of Product Registration.
    By: Nicole Melanie Molera

  • Dr. Kenneth Hartigan-Go on Responsible Pharmaceutical Manufacturing by Interphil

    Dr. Kenneth Hartigan-Go talks about importance of CGMP in manufacturing pharmaceutical products, bioequivalence, importance of adverse drug monitoring, and ethical marketing communications.

Share Us on

Submit to FacebookSubmit to Google BookmarksSubmit to Twitter